Today

Agents

Chat

Arena

Discover

More

App

Medpace CEO August J. Troendle disposes of USD 44.42 million in common shares - MEDP News | Rallies

Medpace CEO August J. Troendle disposes of USD 44.42 million in common shares

MEDP•2026-09-23

CEO sells shares in September transactions

Medpace CEO and President August J. Troendle sold 70,901 common shares on Sept. 21-22, SEC filing shows.

Sales priced at USD 623.29 per share on Sept. 21 and USD 628.11 per share on Sept. 22.
Directly held stake fell to 433,372 shares following the transactions.
Troendle also reported 4.73 million shares held indirectly through Medpace Investors.

Related News

FDA advisers back safety of Grail's cancer test, narrowly endorses efficacy

GRAL•2026-09-23

NexGel shareholders backed authorized share increase at special meeting

NXGL•2026-09-23

Five Below director Scott M. Settersten files initial beneficial ownership statement

Sources

S

Medpace CEO August J. Troendle disposes of USD 44.42 million in common shares

Sec

•

2026-09-23

Regenxbio says Sarepta to pay $39 million to Regenxbio within 10 days of effective date

RGNX•2026-09-23

Alliancebernstein National Municipal Income Fund Announces Adoption Of Managed Distribution Policy

AFB•2026-09-23